Clinical trial
Alkaline Citrate Treatment to Lower the Risk of Nephrocalcinosis in Preterm…
NCT00249951 · University of Cologne, Other · Completed
Key facts
| NCT number | NCT00249951 |
|---|---|
| Title | Alkaline Citrate Treatment to Lower the Risk of Nephrocalcinosis in Preterm Infants |
| Lead sponsor | University of Cologne, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Nephrocalcinosis |
| Intervention type | Drug |
| Interventions | Alkaline citrate |
| Enrollment | 80 |
| Start date | Nov 1, 2005 |
| Primary completion | Nov 1, 2008 |
| Completion | Nov 1, 2008 |
| First posted | Nov 7, 2005 |
| Last update posted | Jul 3, 2012 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: